Sponsors

Lead Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

Breast Cancer Research Foundation
National Cancer Institute (NCI)

1\. Primary Objective Estimate the percent of patients with at least one deficit who agree to at least one referral. "Interest" in the intervention will be determined by this metric. This agreement will be determined within the 1-2 weeks of consenting to the study through interactions between patients and the Study Team. This study will recruit 100 participants in 2 years. These participants will complete the geriatric assessment and be given recommendations based on results. The study team will follow the medical record to determine if the participants complied with the recommendations

Related studies

RECRUITING

A Randomized, Self-controlled Post-marketing Clinical Study on the Comparison of Shengbai Oral Liquid and Leucogen Tablets in the Treatment of Moderate Neutropenia Caused by Anti-tumor Drugs in Breast Cancer Patients

NCT07578064 · Breast Cancer, Bone Marrow Suppression

View all related studies →

LCCC1931:Post-treatment Intervention in Women With Breast Cancer (70y/o+)

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

HER2-PET: Predicting T-DXd Efficacy and HER2 Heterogeneity

RC48-ADC in HER2-low Advanced Breast Cancer

Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

A Randomized, Self-controlled Post-marketing Clinical Study on the Comparison of Shengbai Oral Liquid and Leucogen Tablets in the Treatment of Moderate Neutropenia Caused by Anti-tumor Drugs in Breast Cancer Patients

Trial snapshot

Condition

Locations shown

For caregivers